Milestones expected in 1st half of this year (from presentation)
Ethics approval for BTX 1503 Phase Ia study = Done
DEA export licenses for cannabidiol to be used in clinical studies = Done
Study commencement (and data) for BTX 1503 Phase Ia safety study = June
Study data from PermetrexTM pipeline product = Any day
Sign licensing agreement for PermetrexTM technology with external strategic partner = Any day
New patent filings on other pipeline products = Any day
Exciting times
Ann: Botanix Receives Approval for Synthetic Cannabidiol Trial, page-6
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
31.0¢ |
Change
0.015(5.08%) |
Mkt cap ! $583.3M | |||
| Open | High | Low | Value | Volume |
| 29.5¢ | 31.0¢ | 28.5¢ | $1.848M | 6.223M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 20 | 97350 | 30.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 31.0¢ | 403585 | 17 |
View Market Depth
| Last trade - 13.39pm 18/06/2025 (20 minute delay) ? |
| BOT (ASX) Chart |